Life Sciences: Industry trends & investment considerations with Nick Galakatos, Blackstone
UBS On-Air: Market Moves
00:00
How Blackstone Funds Late-Stage Drug Development
Nick describes investing in products, not companies, providing late‑stage capital in exchange for milestone payments and royalties.
Play episode from 03:37
Transcript
